Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Ideaya Biosciences discloses POLH inhibitors

Dec. 18, 2020

Angex Pharmaceutical presents new PRMT5 inhibitors

Dec. 18, 2020

Agios Pharmaceuticals synthesizes new MAT2A inhibitors

Dec. 18, 2020

VioGen Biosciences patents new PIKfyve inhibitors

Dec. 18, 2020

HSF1 inhibition directly targets treatment-resistant prostate cancer

Dec. 18, 2020

Chordia Therapeutics reports preclinical data for MALT1 inhibitor

Dec. 18, 2020

Pfizer conducts phase I study of PF-07248144 in advanced or metastatic solid tumors

Dec. 18, 2020

Interim phase II data for darolutamide demonstrate efficacy in advanced AR-positive TNBC

Dec. 17, 2020

Positive final data presented from COMBAT/KEYNOTE-202 triple combination study in PDAC

Dec. 17, 2020

Sichuan Haisco Pharmaceutical patents CRBN-comprising PROTACs

Dec. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026